Oxytocin in Individuals With Spectrum Autism Disorders

Trial Profile

Oxytocin in Individuals With Spectrum Autism Disorders

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 18 May 2018

At a glance

  • Drugs Oxytocin (Primary)
  • Indications Autistic disorder
  • Focus Therapeutic Use
  • Acronyms OxytocinASD
  • Most Recent Events

    • 04 May 2018 Planned End Date changed from 29 Jul 2017 to 15 May 2018.
    • 04 May 2018 Status changed from recruiting to active, no longer recruiting.
    • 14 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top